| Pharmaceutical Information |
| Drug Name |
Technetium tc-99m fanolesomab |
| Drug ID |
BADD_D02127 |
| Description |
Not Available |
| Indications and Usage |
Not Available |
| Marketing Status |
approved; experimental |
| ATC Code |
Not Available |
| DrugBank ID |
DB14211
|
| KEGG ID |
D06033
|
| MeSH ID |
C414128
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D07WLI
|
| NDC Product Code |
Not Available |
| UNII |
AMF7KOE318
|
| Synonyms |
techneticum TC-99M fanolesomab | 99Tc-fanolesomab | TC99M RB5 IGM | 99mTc-fanolesomab | RB5 IGM | RB-5 IGM | techneticum (99MTC) fanolesomab | techneticum TC 99M fanolesomab | 99mTc-labeled anti-CD15 MAb | TC-99M RB5 IGM | LeuTech | monoclonal antibody anti-SSEA-1 | anti-SSEA-1 MAb | Neutrospec |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
848033-49-8 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
